A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions

British Journal of Cancer

Volumn 108, Issue 4, 2013, Pages 941-950

  Xu, Z Q ^a,b   Broza, Y Y ^a   Ionsecu, R ^a   Tisch, U ^a   Ding, L ^b   Liu, H ^b   Song, Q ^b   Pan, Y Y ^b   Xiong, F X ^b   Gu, K S ^b   Sun, G P ^b   Chen, Z D ^b   Leja, M ^c   Haick, H ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

Author keywords

breath analysis; diagnosis; gastric cancer; sensor; volatile organic compound

Indexed keywords

2 BUTOXY ETHANOL; 2 PROPENENITRILE; 6 METHYL 5 HEPTEN 2 ONE; FURFURAL; ISOPRENE; NANOMATERIAL; UNCLASSIFIED DRUG;

ADULT; AGED; AMBIENT AIR; ARTICLE; BREATH ANALYSIS; CANCER DIAGNOSIS; CANCER STAGING; CHEMICAL ANALYSIS; FACTORIAL ANALYSIS; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; PEPTIC ULCER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SENSOR; STOMACH CANCER;

BIOLOGICAL MARKERS; BREATH TESTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NANOSTRUCTURES; PILOT PROJECTS; STOMACH NEOPLASMS; STOMACH ULCER; VOLATILE ORGANIC COMPOUNDS;

EID: 84875149422     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.44     Document Type: Article

References (50)

1. Amal H, Ding L, Liu B, Tisch U, Xu Z, Shi D, Zhao Y, Chen J, Sun R, Liu H, Ye S, Tang Z, Haick H (2012) The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs). Int J Nanomedicine 7: 4135-4146.
2. Amann A, Miekisch W, Pleil J, Risby T, Schubert J (2010) Chapter 7: Methodological issues of sample collection and analysis of exhaled breath. Eur Resp Soc Monogr 49: 96-114.
3. Amann A, Spanel P, Smith D (2007) Breath analysis: the approach towards clinical applications. Mini-Rev Med Chem 7(2): 115-129.
4. Atkins L, Benedict EB (1956) Correlation of gross gastroscopic findings with gastroscopic biopsy in gastritis. N Engl J Med 254(14): 641-644.
5. Bajtarevic A, Ager C, Pienz M, Klieber M, Schwarz K, Ligor M, Ligor T, Filipiak W, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Haidenberger A, Buszewski B, Miekisch W, Schubert J, Amann A (2009) Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 9: 348.
6. Barash O, Peled N, Hirsch FR, Haick H (2009) Sniffing the unique 'odor print' of non-small-cell lung cancer with gold nanoparticles. Small 5(22): 2618-2624.
7. Broza YY, Kremer R, Tisch U, Gevorkyan A, Shiban A, Anson Best L, Haick H (2013) A nanomaterial-based breath test for short-term follow-up after lung tumor resection. Nanomedicine 9: 15-21.
8. Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H, Haglund C (2002) CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res 22(4): 2311-2316.
9. Carpenter HA, Talley NJ (1995) Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology 108(3): 917-924.
10. Chen CY, Kuo YT, Lee CH, Hsieh TJ, Jan CM, Jaw TS, Huang WT, Yu FJ (2009) Differentiation between malignant and benign gastric ulcers: CT virtual gastroscopy versus optical gastroendoscopy. Radiology 252: 410-417.
11. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12: 354-362.
12. Dooley CP, Larson AW, Stace NH, Renner IG, Valenzuela JE, Eliasoph J, Colletti PM, Halls JM, Weiner JM (1984) Double-contrast barium meal and upper gastrointestinal endoscopy. A comparative study. Ann Intern Med 101: 538-545.
13. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer: Lyon, France, available at http://globocaniarcfr (accessed on 22 December 2011).
14. Filipiak W, Sponring A, Filipiak A, Ager C, Schubert J, Miekisch W, Amann A, Troppmair J (2010) TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in-vitro. Cancer Epidemiol Biomarkers Prev 19: 182-195.
15. Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, Xiao SD, Lam SK, Goh KL, Chiba T, Uemura N, Kim JG, Kim N, Ang TL, Mahachai V, Mitchell H, Rani AA, Liou JM, Vilaichone RK, Sollano J (2008) Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 23(3): 351-365.
16. Fuchs P, Loeseken C, Schubert JK, MiekischW (2010) Breath gas aldehydes as biomarkers of lung cancer. Int J Cancer 126: 2663-2670.
17. Gordon SM, Szidon JP, Krotoszynski BK, Gibbons RD, Oneill HJ (1985) Volatile organic-compounds in exhaled air from patients with lung-cancer. Clin Chem 31: 1278-1282.
18. Hakim M, Billan S, Tisch U, Peng G, Dvrokind I, Marom O, Abdah-Bortnyak R, Kuten A, Haick H (2011) Diagnosis of head-and-neck cancer from exhaled breath. Br J Cancer 104(10): 1649-1655.
19. Hakim M, Broza YY, Barash O, Peled N, Phillips M, Amann A, Haick H (2012) Volatile organic compounds of lung cancer and possible biochemical pathways. Chem Rev 112(11): 5949-5966.
20. Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, Sobue T (2008) The Japanese guidelines for gastric cancer screening. Japn J Clin Oncol 38(4): 259-267.
21. Hoydonckx HE, Rhijn WMV, Rhijn WV, Vos DED, Jacobs PA (2007) Furfural and derivatives. In Ullmann's Encyclopedia of Industrial Chemistry 2007. Wiley-VCH: Weinheim, Germany.
22. IARC (1999) Re-Evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide. World Health Organization-International Agency for Research on Cancer: Lyon, France.
23. Ionescu R, Broza YY, Shaltieli H, Sadeh D, Zilberman Y, Feng X, Glass-Marmor L, Lejbkowicz I, Mullen K, Miller A, Haick H (2011) Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes. ACS Chem Neurosci 2(12): 687-693.
24. Ionescu R, Llobet E, Vilanova X, Brezmes J, Sueiras JE, Calderer J, Correig X (2002) Quantitative analysis of NO2 in the presence of CO using a single tungsten oxide semiconductor sensor and dynamic signal processing. Analyst 127: 1237-1246.
25. King J, Koc H, Unterkofler K, Mochalski P, Kupferthaler A, Teschl G, Teschl S, Hinterhuber H, Amann A (2010) Physiological modeling of isoprene dynamics in exhaled breath. J Theor Biol 267(4): 626-637.
26. Kischkel S, Miekisch W, Sawacki A, Straker EM, Trefz P, Amann A, Schubert JK (2010) Breath biomarkers for lung cancer detection and assessment of smoking related effects-confounding variables, influence of normalization and statistical algorithms. Clin Chim Acta 411(21-22):1637-1644.
27. Konvalina G, Haick H (2012) Effect of humidity on nanoparticle-based chemiresistors: a comparison between synthetic and real-world samples. ACS Appl Mater Interf 4(1): 317-325.
28. Ligor M, Ligor T, Bajtarevic A, Ager C, Pienz M, Klieber M, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Buszewski B, Miekisch W, Schubert J, Amann A (2009) Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clin Chem Lab Med 47(5): 550-560.
29. McGee DJ, George AE, Trainor EA, Horton KE, Hildebrandt E, Testerman TL (2011) Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37. Antimicrob Agents Chemother 55(6): 2897-2904.
30. Mendis S, Sobotka PA, Euler DE (1994) Pentane and isoprene in expired air from humans: gas-chromatographic analysis of single breath. Clin Chem 40: 1485-1488.
31. Miekisch W, Schubert JK, Noeldge-Schomburg GFE (2004) Diagnostic potential of breath analysis-focus on volatile organic compounds. Clin Chim Acta 347: 25-39.
32. O'Neill HJ, Gordon SM, O'Neill MH, Gibbons RD, Szidon JP (1988) A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. Clin Chem 34: 1613-1618.
33. Peng G, Tisch U, Adams O, Hakim M, Shehada N, Broza YY, Billan S, Abdah-Bortnyak R, Kuten A, Haick H (2009) Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol 4(10): 669-673.
34. Peng S, Hakim M, Broza Y, Billan S, Abdah-Brotnyak R, Kuten A, Tisch U, Haick H (2010) Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer 103: 542-551.
35. Phillips M, Gleeson K, Hughes JMB, Greenberg J, Cataneo RN, Baker L, McVay WP (1999) Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 353: 1930-1933.
36. Phillips M, Greenberg J, Awad J (1994) Metabolic and environmental origins of volatile organic compounds in breath. J Clin Pathol 47: 1052-1053.
37. Pisters PT, Kelson DP, Tepper JE (2008) Cancer of the stomach. In: DeVita VT, Lawrence TS, Rosenberg SA (eds) 8th edn). DeVita, Hellman, and Rosenberg's Cancer, Principles and Practice of Oncology Vol. 1, Chapter 39, section 3, pp 1043-1079. Wolters Kluwer: Philadelphia, PA.
38. Shuster G, Gallimidi Z, Heyman-Reiss A, Dovgolevsky E, Billan S, Abdah-Bortnyak R, Kuten A, Engel A, Shiban A, Tisch U, Haick H (2010) Classification of breast cancer precursors through exhaled breath. Breast Cancer Res Treat 126: 791-796.
39. Song G, Qin T, Liu H, Xu G, Pan YY, Xiong FX, Gu KS, Sun GP, Chen ZD (2010) Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer 67(2): 227-231.
40. Sponring A, Filipiak W, Mikoviny T, Ager C, Schubert J, Miekisch W, Amann A, Troppmair J (2009) Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. Anticancer Res 29: 419-426.
41. Suzuki H, Gotoda T, Sasako M, Saito D (2006) Detection of early gastric cancer: misunderstanding the role of mass screening. Gastric Cancer 9: 315-319.
42. Tisch U, Aluf Y, Ionescu R, Nakhleh M, Bassal R, Axelrod N, Robertman D, Tessler Y, Finberg JPM, Haick H (2011) Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors. ACS Chem Neurosci 3(3): 161-166.
43. Tisch U, Haick H (2010a) Arrays of chemisensitive monolayer-capped metallic nanoparticles for diagnostic breath testing. Rev Chem Eng 26: 171-179.
44. Tisch U, Haick H (2010b) Nanomaterials for cross-reactive sensor arrays. MRS Bull 35: 797.
45. Tisch U, Haick H (2010c) Sensors based on monolayer-capped metal nanoparticles. In Chemical Sensors-Vol. 2: Nanostructured Materials, Korotcenkov G (ed), Momentum Press: LLC, New York, Vol. 2, (Nanstructured Materials), Chapter 4, pp 141-202.
46. Tytgat GN (1991) The Sydney System: endoscopic division. Endoscopic appearances in gastritis/duodenitis. J Gastroenterol Hepatol 6: 223-234.
47. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I (2007) Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8(9): 784-796.
48. Wehinger A, Schmid A, Mechtcheriakov S, Ledochowski M, Grabmer C, Gastl GA, Amann A (2007) Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas. Int J Mass Spectrom 265(1): 49-59.
49. Wilkoxon F (1945) Individual comparisons by ranking methods. Biomet Bull 1: 80-83.
50. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H (2005) Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 8: 86-94.